Literature DB >> 30772928

Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway.

Marta Szybowska1, Ozgur Mete2, Evan Weber3, Josh Silver1,4, Raymond H Kim5,6,7.   

Abstract

Neuroendocrine neoplasms (NENs) have been primarily associated with germline pathogenic variants in genes involved in chromatin remodeling (MEN1), cell cycle control (CDKN1B), PI3K/mTOR signaling (TSC1/2, PTEN) as well as pseudohypoxia (VHL, SDHx). Recent work has implicated various genes involved in DNA repair pathways in the pathophysiology of a subset of pancreatic neuroendocrine neoplasms, including BRCA2, via the homologous recombination pathway (HRD). To date, germline variants in other HRD pathway genes have not been described to contribute to NEN. PALB2, RAD51C, and BARD1 are additional tumor suppressor genes which also mediate repair of double stranded DNA breaks through the HRD pathway and are implicated in hereditary breast (PALB2; BARD1) and ovarian (RAD51C) cancer. Here we report three cases of NEN associated with germline pathogenic variants in PALB2 (pancreatic NEN), RAD51C (thymic NEN), and BARD1 (pancreaticoduodenal NEN) respectively, further linking the DNA repair pathway to NENs.

Entities:  

Year:  2019        PMID: 30772928     DOI: 10.1007/s12022-019-9569-4

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  7 in total

Review 1.  Molecular Pathology of Well-Differentiated Gastro-entero-pancreatic Neuroendocrine Tumors.

Authors:  Sylvia L Asa; Stefano La Rosa; Olca Basturk; Volkan Adsay; Marianna Minnetti; Ashley B Grossman
Journal:  Endocr Pathol       Date:  2021-01-18       Impact factor: 3.943

Review 2.  Genomics of High-Grade Neuroendocrine Neoplasms: Well-Differentiated Neuroendocrine Tumor with High-Grade Features (G3 NET) and Neuroendocrine Carcinomas (NEC) of Various Anatomic Sites.

Authors:  Silvia Uccella; Stefano La Rosa; Jasna Metovic; Deborah Marchiori; Jean-Yves Scoazec; Marco Volante; Ozgur Mete; Mauro Papotti
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

3.  Clinical significance of RAD51C and its contribution to ovarian carcinogenesis.

Authors:  Xiao-Li Lu; Si-Sun Liu; Zhen-Fang Xiong; Fen Wang; Xia-Ying Li; Huan Deng
Journal:  Int J Clin Exp Pathol       Date:  2020-01-01

Review 4.  The Effects of Genetic and Epigenetic Alterations of BARD1 on the Development of Non-Breast and Non-Gynecological Cancers.

Authors:  Andrea K Watters; Emily S Seltzer; Danny MacKenzie; Melody Young; Jonathan Muratori; Rama Hussein; Andrej M Sodoma; Julie To; Manrose Singh; Dong Zhang
Journal:  Genes (Basel)       Date:  2020-07-21       Impact factor: 4.096

5.  Co-occurrence of breast cancer and neuroendocrine tumours: New genetic insights beyond Multiple Endocrine Neoplasia syndromes.

Authors:  Vincent Larouche; Amit Akirov; Emily Thain; Raymond H Kim; Shereen Ezzat
Journal:  Endocrinol Diabetes Metab       Date:  2019-09-08

Review 6.  Molecular Pathology of Well-Differentiated Pulmonary and Thymic Neuroendocrine Tumors: What Do Pathologists Need to Know?

Authors:  Marco Volante; Ozgur Mete; Giuseppe Pelosi; Anja C Roden; Ernst Jan M Speel; Silvia Uccella
Journal:  Endocr Pathol       Date:  2021-02-27       Impact factor: 3.943

Review 7.  Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective.

Authors:  Michele Prisciandaro; Maria Antista; Alessandra Raimondi; Francesca Corti; Federica Morano; Giovanni Centonze; Giovanna Sabella; Alessandro Mangogna; Giovanni Randon; Filippo Pagani; Natalie Prinzi; Monica Niger; Salvatore Corallo; Erica Castiglioni di Caronno; Marco Massafra; Maria Di Bartolomeo; Filippo de Braud; Massimo Milione; Sara Pusceddu
Journal:  Front Oncol       Date:  2022-02-04       Impact factor: 6.244

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.